NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,741 | -82.9% | 3,823 | -56.1% | 0.00% | -83.3% |
| Q2 2023 | $361,673 | +107221.4% | 8,715 | +55.8% | 0.01% | +9.1% |
| Q1 2023 | $337 | -22.7% | 5,593 | -5.9% | 0.01% | -38.9% |
| Q4 2022 | $436 | -99.2% | 5,944 | +705.4% | 0.02% | +1700.0% |
| Q3 2022 | $57,000 | -70.9% | 738 | -73.9% | 0.00% | -75.0% |
| Q2 2022 | $196,000 | -76.7% | 2,827 | -72.2% | 0.00% | -50.0% |
| Q1 2022 | $841,000 | +3.2% | 10,155 | -6.5% | 0.01% | -42.9% |
| Q4 2021 | $815,000 | +2228.6% | 10,857 | +3471.4% | 0.01% | +1300.0% |
| Q3 2021 | $35,000 | -98.7% | 304 | -97.4% | 0.00% | -98.5% |
| Q2 2021 | $2,630,000 | +212.7% | 11,854 | +86.4% | 0.07% | +385.7% |
| Q1 2021 | $841,000 | -40.6% | 6,360 | -22.2% | 0.01% | -67.4% |
| Q4 2020 | $1,415,000 | +31.8% | 8,180 | -15.2% | 0.04% | +258.3% |
| Q3 2020 | $1,074,000 | -23.6% | 9,649 | -59.3% | 0.01% | -79.3% |
| Q2 2020 | $1,405,000 | +264.0% | 23,686 | +417.7% | 0.06% | +81.2% |
| Q4 2019 | $386,000 | +365.1% | 4,575 | +246.6% | 0.03% | +433.3% |
| Q2 2019 | $83,000 | +730.0% | 1,320 | +560.0% | 0.01% | +500.0% |
| Q1 2019 | $10,000 | +233.3% | 200 | +100.0% | 0.00% | – |
| Q4 2018 | $3,000 | -92.5% | 100 | -86.9% | 0.00% | -100.0% |
| Q3 2018 | $40,000 | -29.8% | 763 | -73.2% | 0.00% | -57.1% |
| Q4 2017 | $57,000 | -71.4% | 2,845 | -71.6% | 0.01% | -56.2% |
| Q3 2017 | $199,000 | +210.9% | 10,000 | +170.3% | 0.02% | +128.6% |
| Q2 2017 | $64,000 | +3100.0% | 3,700 | +1750.0% | 0.01% | – |
| Q2 2016 | $2,000 | -86.7% | 200 | -80.3% | 0.00% | -100.0% |
| Q1 2016 | $15,000 | +150.0% | 1,014 | +308.9% | 0.00% | +100.0% |
| Q4 2015 | $6,000 | – | 248 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 470,884 | $39,681,000 | 20.12% |
| HARTLINE INVESTMENT CORP/ | 330,672 | $27,866,000 | 5.97% |
| MORGAN JESS S & CO INC | 52,889 | $4,457,000 | 4.37% |
| Darsana Capital Partners LP | 1,350,000 | $113,765,000 | 3.88% |
| Rhenman & Partners Asset Management AB | 350,000 | $29,495,000 | 3.23% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $843,000 | 2.55% |
| Taylor Frigon Capital Management LLC | 38,073 | $3,208,000 | 2.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,500 | $2,991,000 | 1.08% |
| Granite Investment Partners, LLC | 261,315 | $22,021,000 | 1.04% |
| Nicholas Investment Partners, LP | 85,835 | $7,233,000 | 0.74% |